Tilray Brands (TLRY) Stock Price, News & Analysis

Company Overview

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

Key Stats

• Today's Range: C$0.67 to C$0.70
• 50-Day Range: C$0.50 to C$0.69
• 52-Week Range: C$0.49 to C$2.97
• Volume: 696,847 shs
• Average Volume: 1.59 million shs
• Market Capitalization: C$431.73 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TLRY Stock Analysis - Frequently Asked Questions

How have TLRY shares performed this year?

Tilray Brands' stock was trading at C$1.90 at the beginning of 2025. Since then, TLRY stock has decreased by 64.7% and is now trading at C$0.67.

How do I buy shares of Tilray Brands?

Shares of TLRY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Tilray Brands own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include Meta Platforms (META), Enbridge (ENB), NVIDIA (NVDA), PayPal (PYPL), Enterprise Products Partners (EPD), Tesla (TSLA).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:TLRY
• Previous Symbol: TSE:TLRY
• CIK: N/A
• Web: www.tilray.com
• Phone: 12064329325
• Fax: N/A
• Employees: 2,650
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$183.24 million
• Net Margins: -30.02%
• Pretax Margin: N/A
• Return on Equity: -7.24%
• Return on Assets: -1.41%

Debt

• Debt-to-Equity Ratio: 10.76
• Current Ratio: 2.54
• Quick Ratio: 2.16

Sales & Book Value

• Annual Sales: C$610.34 million
• Price / Sales: 0.71
• Cash Flow: C$0.11 per share
• Price / Cash Flow: 5.95
• Book Value: C$3.94 per share
• Price / Book: 0.17

Miscellaneous

• Outstanding Shares: 644,367,091
• Free Float: N/A
• Market Cap: C$431.73 million
• Optionable: Not Optionable
• Beta: 2.19